D-Cycloserine CAS:68-41-7

D-Cycloserine is utilized in the management of tuberculosis infections, particularly in cases of drug-resistant tuberculosis. It is considered a second-line agent and is often included in treatment regimens for patients who do not respond to first-line medications or who have developed resistance to them. D-Cycloserine works by disrupting cell wall synthesis in tuberculosis-causing bacteria, leading to their destruction. When prescribing D-Cycloserine, healthcare providers consider factors such as the patient's medical history, the severity of the infection, and any potential drug interactions. Close monitoring for adverse effects, such as central nervous system symptoms like dizziness, confusion, or seizures, is essential during treatment with D-Cycloserine. Patients receiving D-Cycloserine therapy should be educated about the importance of adherence to the prescribed regimen to prevent the development of further drug resistance. Regular follow-up appointments and monitoring of liver and kidney function may also be necessary to ensure treatment efficacy and safety. In conclusion, D-Cycloserine is a valuable antibiotic for the management of drug-resistant tuberculosis infections. Its use in combination therapy under careful medical supervision can help improve treatment outcomes and contribute to the control of tuberculosis, especially in cases where standard treatments are ineffective.